Researchers have made a fascinating discovery about probiotics and their role in preventing COVID-19 infection. Their study suggests that probiotics, particularly lactobacillus, could delay infection and reduce symptoms in unvaccinated people who had been in contact with COVID-19 patients in their household.
The study, led by Duke Health researchers, suggests that the use of probiotics is a simple and inexpensive approach to treating people after exposure to COVID-19. The results of the study were published in Clinical Nutrition.
“Prior to COVID, there was strong evidence that probiotics were protective against respiratory infections. Once COVID hit, it was imperative to determine whether this simple, well-tolerated intervention could be useful. Our study provides encouraging evidence for the use of probiotics,” said Dr. Paul Wischmeyer, co-lead author of the study.
The participants were unvaccinated people who had been exposed to someone with COVID-19 infection but had not yet developed symptoms. Out of 182 participants, half were given a probiotic of lactobacillus, while the other half were given a placebo pill.
“Upon analysis, the researchers found that participants randomized to receive the probiotic were 60% less likely to develop COVID symptoms compared to those randomized to receive placebo—26.4% vs. 42.9%. The probiotic participants were also able to stave off infection longer compared to those receiving the dummy pill,” the researchers wrote in a news release.
However, since the study size was small, the probiotic group did not meet a statistically significant reduction in the incidence of COVID-19 (8.8% COVID diagnosis rate in probiotics vs. 15.4% COVID diagnosis rate in the control group).
“We are actually not surprised by these findings. There have been several studies that have demonstrated the strong efficacy of probiotics against respiratory infections, including a very large study among babies in India that was published in Nature in 2017. Other…
Read the full article here
Leave a Reply